0001883850-22-000058.txt : 20220817
0001883850-22-000058.hdr.sgml : 20220817
20220817160435
ACCESSION NUMBER: 0001883850-22-000058
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220815
FILED AS OF DATE: 20220817
DATE AS OF CHANGE: 20220817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MURPHY ANDREW J
CENTRAL INDEX KEY: 0001796226
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 221173979
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-08-15
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001796226
MURPHY ANDREW J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP Research
Common Stock
2022-08-15
4
M
0
10000
179.13
A
68470
D
Common Stock
2022-08-15
4
F
0
6487
634.25
D
61983
D
Common Stock
2022-08-16
4
S
0
76
639.85
D
61907
D
Common Stock
2022-08-16
4
S
0
148
640.91
D
61759
D
Common Stock
2022-08-16
4
S
0
537
641.47
D
61222
D
Common Stock
2022-08-16
4
S
0
329
642.53
D
60893
D
Common Stock
2022-08-16
4
S
0
94
643.37
D
60799
D
Common Stock
2022-08-16
4
S
0
332
644.49
D
60467
D
Common Stock
2022-08-16
4
S
0
119
645.63
D
60348
D
Common Stock
2022-08-16
4
S
0
325
646.44
D
60023
D
Common Stock
2022-08-16
4
S
0
701
647.73
D
59322
D
Common Stock
2022-08-16
4
S
0
766
648.78
D
58556
D
Common Stock
2022-08-16
4
S
0
86
649.54
D
58470
D
Common Stock
4290
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
179.13
2022-08-15
4
M
0
10000
0.0
D
2022-12-14
Common Stock
10000
10000
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 148 shares of Company stock on August 16, 2022 at prices ranging from $640.88 to $640.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 537 shares of Company stock on August 16, 2022 at prices ranging from $641.00 to $641.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 329 shares of Company stock on August 16, 2022 at prices ranging from $642.13 to $642.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 94 shares of Company stock on August 16, 2022 at prices ranging from $643.33 to $643.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 332 shares of Company stock on August 16, 2022 at prices ranging from $644.10 to $644.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 119 shares of Company stock on August 16, 2022 at prices ranging from $645.49 to $645.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 325 shares of Company stock on August 16, 2022 at prices ranging from $646.27 to $646.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 701 shares of Company stock on August 16, 2022 at prices ranging from $647.20 to $647.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
Represents volume-weighted average price of sales of 766 shares of Company stock on August 16, 2022 at prices ranging from $648.17 to $648.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Andrew Murphy
2022-08-17